Skip to main content
Log in

HPLC determination and steady-state bioavailability study of levodropropizine sustained-release tablets in dogs

  • Articles
  • Drug Efficacy
  • Published:
Archives of Pharmacal Research Aims and scope Submit manuscript

Abstract

A simple HPLC method using UV detection was developed and validated for the determination of levodropropizine (LDP) in dog plasma. The sample was prepared for injection using a liquid-liquid extraction method with 1-phenypiperazine as the internal standard. The mobile phase was methanol—diethylamine solution (0.05 M) (20∶80, v/v, pH adjusted to 3.0 with H3PO4) with a detection wavelength of 240 nm. The limit of quantitation (LOQ) of LDP in a biological matrix was determined to be 25.25 ng/mL. The calibration curve was linear across the concentration range of 25.25 to 2020 ng/mL. The intra-day and inter-day precision values (CV %) were within 7% and accuracy (R.E.%) was within 6% of the nominal values for medium (252.5 ng/mL) and high (2020 ng/mL) LDP concentrations. For the LDP concentration at the LOQ, the intra-day and inter-day precision and accuracy were within 20% and 10%, respectively. The average absolute recovery for LDP was 70.28%. This method was successfully used to analyze plasma samples in a steady-state bioavailability study of a newly developed sustained-release LDP tablets (SR) using immediate-release tablets (IR) as the reference. The relative bioavailability of the SR was determined to be 106.3±12.8% (n=6). The Cmax of the SR was significantly lower (P<0.05) and the tmax was significantly longer than that of the IR (P<0.05). The results of ANOVA and two one-sided tests indicated that the SR exhibited acceptable sustained release properties and was bioequivalent to the IR.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Borsa, M., Glavenna, G., Ferrari, M. P., Canali, S., Giachetti, C., and Zanolo, G., Linearity of levodropropizine, a new antitussive drug, in the healthy volunteer.Eur. J. Drug. Metab. Pharmacokinet., 3, 178–184 (1991).

    Google Scholar 

  • Bressolle, F., Bromet-Petit, M., and Audran, M., Validation of liquid chromatographic and gas chromatographic methods applications to pharmacokinetics.J. Chromatogr. B Biomed. Appl., 686, 3–10 (1996).

    Article  PubMed  CAS  Google Scholar 

  • Causon, R., Validation of chromatographic methods in biomedical analysis. Viewpoint and discussion.J. Chromatogr. B Biomed. Sci. Appl., 689, 175–180 (1997).

    Article  PubMed  CAS  Google Scholar 

  • FDA, Guidance for Industry: Statistical Approaches to Establishing Bioequivalence. Center for Drug Evaluation and Research (CDER), United States Food and Drug Administration, (1997).

  • Hartmann, C., Smeyers-Verbeke, J., Massart, D. L., and McDowall, R. D., Validation of bioanalytical chromatographic methods.J. Pharm. Biomed. Anal., 17, 193–218 (1998).

    Article  PubMed  CAS  Google Scholar 

  • Hu, X. Z., Yu, J. X., and Lin, Y. F., Determination of levodropropizine in serum by tandem gas chromatography-mass spectrometry.Analysis And Testing Technology Andinstruments, 6, 228–231 (2000).

    Google Scholar 

  • Malandrino, S., Melillo, G., Bestetti, A., Borsa, M., Giuliani, P., and Tonon, G. C., Antitussive properties of levodropropizine.Arzneimittelforschung, 38, 1141–1143 (1988).

    PubMed  CAS  Google Scholar 

  • Melillo, G., Malandrino, S., Rossoni, G., Caselli, G., Bestetti, A., Borsa, M., Tonon, G. C., and Berti, F., General pharmacology of the new antitussive levodropropizine.Arzneimittelforschung., 38, 1144–1150 (1988).

    PubMed  CAS  Google Scholar 

  • SFDA, Guidance: Bioavailability and Bioequivalence studies for drug products in human being. The State Food and Drug Administration of China, (2004).

  • Tagliaro, F., Moffa, M., De Battisti, Z., Smith, F. P., and Gentile, M., High-performance liquid chromatographic determination of levodropropizine in human plasma with fluorometric detection.J. Chromatogr. B Biomed. Appl., 685, 165–170 (1996).

    Article  PubMed  CAS  Google Scholar 

  • Zaratin, P., De Angelis, L., and Cattabeni, F., Gas chromatographic-mass spectrometric determination of levodropropizine plasma levels in healthy volunteers.Arzneimittelforschung., 38, 1156–1158 (1988).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lin Yan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yan, L., Li, T., Zhang, R. et al. HPLC determination and steady-state bioavailability study of levodropropizine sustained-release tablets in dogs. Arch Pharm Res 29, 514–519 (2006). https://doi.org/10.1007/BF02969426

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02969426

Key words

Navigation